4//SEC Filing
Zakrzewski Joseph S 4
Accession 0001209191-22-028574
CIK 0001662244other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:35 PM ET
Size
11.9 KB
Accession
0001209191-22-028574
Insider Transaction Report
Form 4
Zakrzewski Joseph S
Director
Transactions
- Purchase
Common Stock
2022-05-10$1.89/sh+49,406$93,377→ 131,673 total - Purchase
Common Stock
2022-05-11$1.70/sh+1,000$1,700→ 132,673 total
Holdings
- 58,671(indirect: See Footnote)
Common Stock
- 149,051(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $1.67 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]55,102 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
- [F3]Shares held by Z Investments, LLC, of which the Reporting Person is the Managing Director. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
- [F4]Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
Documents
Issuer
Cyteir Therapeutics, Inc.
CIK 0001662244
Entity typeother
Related Parties
1- filerCIK 0001331852
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:35 PM ET
- Size
- 11.9 KB